Observational studyBMJ open diabetes research & care2020

Cardiovascular outcomes of type 2 diabetic patients treated with SGLT-2 inhibitors versus GLP-1 receptor agonists in real-life.

Enrico Longato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.